Form SCHEDULE 13D/A Wearable Devices Ltd. Filed by: Daniel Nissim

Item 4 of the Schedule 13D is hereby amended to add the following at the end thereof: On July 31, 2026, the Issuer announced that it entered into a securities purchase agreement with a single institutional investor in a private placement transaction for the purchase and sale of 1,000,000 Ordinary Shares (or Ordinary Share equivalents in lieu thereof) and warrants to purchase up to 1,000,000 Ordinary Shares at a combined purchase price of $3.285 per share and accompanying warrant (the "Private Placement"). On August 1, 2026, the Reporting Persons communicated to the Issuer their objection to the proposed Private Placement and demanded that the Issuer refrain from consummating it. The Reporting Persons asserted, among other things, that the Private Placement would improperly alter the Issuer's capital structure and voting dynamics and affect matters that may be considered by the Issuer's shareholders in connection with the issues previously raised by the Reporting Persons in their prior demand for a special meeting of shareholders. The Reporting Persons further asserted that the Private Placement was not in the best interests of the Issuer and its shareholders and requested that the Issuer take no further action to proceed with the closing of the Private Placement. On August 2, 2026, the Issuer responded and rejected the Reporting Persons' position, asserting, among other things, that the Private Placement was a market-priced financing undertaken in the ordinary course of the Issuer's business, that the Issuer had a continuing need to raise capital to fund its operations and growth, and that the Private Placement would not impair the ability of shareholders to pursue the matters raised in the Reporting Persons' demand for a special meeting of stockholders. On August 2, 2026, the Reporting Persons commenced proceedings in the Economic Department of the District Court of Haifa, Israel (the "Court"), seeking temporary injunctive relief in connection with the Private Placement. On August 2, 2026, the Court issued an ex parte temporary injunction, scheduled a hearing for August 16, 2026, and temporarily prohibited the Issuer from advancing the Private Placement or otherwise modifying its capital structure, pending further order. The Court noted that its decision was issued at a preliminary stage of the proceedings and on an ex parte basis, prior to receiving the positions of the Issuer or the investor in the Private Placement, and that its decision should not be construed as a determination regarding the outcome of the application. The Reporting Persons intend to continue pursuing their rights and remedies in connection with the foregoing matters.